ivdr post market surveillance

This includes the requirement of implementing appropriate and necessary CAPA activities and communication with competent authorities regarding: The IVDR expands PMS activity requirements, even for those manufacturers who are ISO13485:2016 compliant, as the standard is not explicit enough to meet requirements of Article 78. Article 10, 9. lays down the requirement for all Manufacturers to have a Post Market Surveillance (PMS) System. Clinical Performance Studies: Very comparable to the MDR, requirements for carrying out clinical performance studies increased dramatically. This is shown by Articles 57 et seqq. Post-market surveillance under the MDR/IVDR. Post-market surveillance data and information has to be included in the post-market section of the Clinical Evaluation Report (CER). Previously, NAMSA’s blog series discussed the QMS application under the IVDR. They are intended to provide the objective evidence of safety, performance, … It is the collection of the feedbacks loops which have a longer response time than say the vigilance process or the complaint process. update the summary of safety and performance (if applicable). Post-market surveillance under the MDR and IVDR. Webinar. III. The report should summarize the results of any data analysis done, as well as any CAPAs opened and the proposed action plan. 4 Pillars of IVDR: Integrating Post-Market Surveillance, Risk Management, QMS & Performance Evaluation. The PMS report is part of the Technical Documentation on Post Market Surveillance (Annex III, 2.). The Periodic Safety Update Report (PSUR) is a document summarising the results and conclusions of the analysis of Post-Market Surveillance (PMS) data with usage data.. The MDR obliges manufacturers to proactively collect and evaluate clinical data from the end … There are new processes, including Post-Market Performance Follow-Up (PMPF), Periodic Safety Update Reporting (PSUR) and Post-Market Surveillance Planning and Reporting (PMSP/PMSR), all with an emphasis on the product lifecycle. Post Market Surveillance System Article 10, 10. lays down the requirement for all Manufacturers to have a Post Market Surveillance (PMS) System. It is also connected to varied levels of QMS processes such as: A PMS system is an integral part of any IVDR-compliant QMS and is key in establishing a robust systems and long-term success. Don’t miss our e-Learning on IVDR implementation strategies.In a series of 9 sessions we will help you to understand how the new IVDR will affect your product.Within this e-Learning you will learn what the new requirements for post-market surveillance (PMS) and vigilance are under the IVDR and what the new requirements on trend reporting and post-market performance follow-up Home; Recent events; FAQ; IVDD comparison; About; Contact; Mentorships; Post Market Surveillance planning. Post-market surveillance aims to ensure that IVDs continue to meet the same quality, safety and performance requirements as when they were initially placed on the market. Moreover, with the dates of application for the two Regulations fast approaching, it is crucial that manufacturers get to grips with these new requirements without delay. 1 Post-market surveillance 2. if applicable, to contribute to the post-market surveillance of other devices. The feedback information in the PMS system is use to: Therefore, when designing a PMS system, one must start by considering the types of information those eight or nine processes use as feedback. Post-Market Surveillance Requirements Guide to Manufacturers Law.eu MDR/IVDR IMPLEMENTATION TOOLS JANUARY 2019 Any reproduction or further dissemination of this publication is not allowed, unless prior written approval is provided by the Content Manager of MDlaw.eu (contact: mdlaw@obelis.net). The following 157 pages were published in the . Introduction – Post Market Surveillance & Adverse Event Reporting. To begin, it is important to understand how PMS is defined under the IVDR: “‘all activities carried out by manufacturers in cooperation with other economic operators to institute and keep up to date a systematic procedure to proactively collect and review experience gained from devices they place on the market, make available on the market or put into service for the purpose of identifying any need to immediately apply any necessary corrective or preventive actions.” Annex 2 (63). Post-market surveillance activities must be established, implemented and maintained in accordance with Article 78, and, as stated in the IVDR, this must be an integral part of the QMS (see Figure 1). New Requirements for Post-market Surveillance. Post-market surveillance data and information has to be included in the post-market section of the Clinical Evaluation Report (CER). Post-Market Surveillance: Manufacturers must precisely plan and carry out post-market surveillance. Introduction – Post Market Surveillance & Adverse Event Reporting. 2 Background to changes The Medical Devices Regulation (MDR) (Regulation (EU) 2017/745) and In Vitro Medical Device Regulation (IVDR) (Regulation (EU) 2017/746) are significant changes to European legislation for medical devices. Data like complaints and incidents. Post Market Surveillance (PMS) is primarily concerned with establishing the PMS plan for the device. Webinar. His work covered regulatory documentation such as design initiation, design scope, design history, verification and validation of the project and transfer of product. How these activities will be executed … • Post-market surveillance: • Overview • Interpret regulatory requirements for post-market surveillance and vigilance under the MDR and IVDR • Why is Post-Market Surveillance (PMS) necessary? identify necessary preventive, corrective or field safety corrective action. Data which has to first be collected, and then assessed in order to produce the needed feedback information. One of the areas that has been changed substantially in the new Regulations relates to the ongoing oversight by the manufacturer of devices once they are on the market. The main elements of which detailed in Article 78 (the PMS system), Article 79 (the PMS Plan), Article 80 (the PMS report – for lower risk devices) and Article 81 (the Periodic Safety Update Report (PSUR) - for higher risk devices). The Person Responsible for Regulatory Compliance (PRRC) is, under the MDR and the IVDR, a person responsible for ensuring compliance with the MDR/IVDR requirements regarding the conformity of the devices, the technical documentation, the EU declaration of conformity, the post-market surveillance obligations and the reporting of serious incidents and field safety corrective … Download this free excerpt from Compliance Navigator's Smart Support series of expert commentaries on the MDR/IVDR for: Insight into the background to the changes to EU post-market … Post-market activities, as outlined within the IVDR, are a major step up from the requirements of the outdated IVDD. Email. The incorporation of the plan into the QMS as either a procedure or a template to be completed as part of a device’s technical file, may also be used. 2 Background to changes The Medical Devices Regulation (MDR) (Regulation (EU) 2017/745) and In Vitro Medical Device Regulation (IVDR) (Regulation (EU) 2017/746) are significant changes to European legislation for medical devices. The feedback information required by each process is different: The risk management process requires information about the frequency and severity of harm which results from using the device, manufacturing requires information about nonconformities, the clinical evaluation requires information on clinical performance and so on. Article 79 requires that the PMS System is based on a plan, although the details of the plan are specified in Annex III, 1.1. PMPF is addressed in the PMSP and outputs are documented in a PMPF evaluation report (PMPFR). Quality, performance and safety of a device are the focus of a well-structured PMS system, and should actively and systematically gather, record and analyze relevant data throughout a device’s lifetime. The main elements of which detailed in Article 83 (the PMS system), Article 84 (the PMS Plan), Article 85 (the PMS report – for lower risk devices) and Article 86 (the Periodic Safety Update Report (PSUR) - for higher risk devices). Clinical Performance Studies: Very comparable to the MDR, requirements for carrying out clinical performance studies increased dramatically. The plan must be approved by your notified body before you execute it since as per the new MDR and the IVDR, the NBs play a more active role in the pre and post-market activities of the company. Post-market surveillance for in vitro diagnostics (IVDs) Post-market surveillance aims to ensure that IVDs continue to meet the same quality, safety and performance requirements as when they were initially placed on the market. The PMPF is a proactive collection and evaluation of the performance and relevant data from the use of a device as described in Annex XIII (part B). For example, ISO13485:2016 mentions PMS activities in Section 8.2.1 regarding feedback processes which should include provision to gather data from production, as well as post-production activities and 8.5.1 improvement actions from QMS sections including PMS. Post-market surveillance under the MDR/IVDR. Post-market surveillance consists of reactive post-market surveillance after an issue has occurred related to the IVD, and proactive post-market surveillance to scan for potential issues related to the IVD. This is your article 92 from the MDR obligation, and that correlates with the article 87 in the IVDR. Article 78 states that manufacturers should have for each device, a well-structured PMS system that is appropriate for the risk class and device type (see previous NAMSA blog on IVDR technical documentation and risk). Article 84 requires just such a plan. This is shown by Articles 57 et seqq. … These are intended to confirm that devices on the market do not endanger health, safety or any other aspect of public interest. While Post Market Surveillance (PMS) is not mentioned in current In Vitro Diagnostics Device Directive (IVDD). They are intended to provide the objective evidence of safety, … The IVDR Preamble (75) gives direction that manufactures are to play an active role during the post-market phase of the product lifecycle. Important elements revolve around maintaining quality, performance and safety throughout the product lifecycle. BSI takes your privacy seriously. Post-market surveillance activities must be established, implemented and maintained in accordance with Article 78, and, as stated in the IVDR, this must be an integral part of the QMS (see Figure 1). TABLE OF CONTENTS. To summarize, IVDR mandates that PMS must be comprised of the following elements: This expanded requirement for IVD manufacturers will evolve the pathways of change for devices previously observed in the marketplace. At this point it’s also worth reflecting on the purpose. This represents the entirety of the European IVDR. Last Name. Further, Warren is expert at reviewing technical files and guiding IVD sponsors on the pathway to IVDR compliance. Post-Market Surveillance, Market Surveillance & Vigilance. Due to these requirements, it is imperative that surveillance programs be implemented with a formal Post-Market Surveillance Plan (PMSP). Official Journal of the European Union on 5 May 2017. and in Annex III. Gain insight into post-market surveillance for medical devices and in vitro diagnostic devices under the EU Regulations with this free download. It has to be produced from assessing different, more fundamental, data. Section 6 describes the review of this plan. The process to continuously update the clinical evaluation with this data is called Post-Market Clinical Follow-up (PMCF) and outlined in Part 2 of Annex XIV. The data gathered through PMS activities, such as Corrective Actions and Preventative Actions (CAPA), should be used to update technical documentation—for example, updates to risk management assessments, risk reports, performance evaluations—showing consistent, regular updates to PMS. Post-market surveillance (PMS) is defined as "a systematic process to derive necessary corrective and preventive actions (CAPA) from information on medical devices already placed on the market".Content overview. As products are the output of various processes within a quality management system, it is beneficial to discuss vigilance, post-market clinical planning and data as a critical part of the design dossier and/or technical documentation of a device. POWERED B OBELIS ROUP Law.eu 2/28 AUTHOR: ROLAND ERARD - … Your post-market surveillance will tell the whole story about how well your plan was executed. Furthermore, the PMS must be planned, documented, implemented, maintained, updated and integrated into the manufacturer’s QMS explained in article 10(8) and within the following blog post. Need to know more about the IVDR? update the benefit-risk determination and to improve the risk management. The Manufacturer’s obligation to maintain a “systematic procedure to review experience gained from devices in the post-production phase” (IVDD Annex III (5) and other references) is generally considered to be synonymous with a requirement to have a PMS system. PMS processes should then inform the Performance Evaluation Report (PER) that is part of the technical documentation. As a reminder, Article 10(8i) states that a PMS system must be created and implemented and Article 10(9) states that this system must be kept up-to-date in accordance with Article 78. BSI takes your privacy seriously. Post-Market Surveillance Requirements Guide to Manufacturers Law.eu MDR/IVDR IMPLEMENTATION TOOLS JANUARY 2019 Any reproduction or further dissemination of this publication is not allowed, unless prior written approval is provided by the Content Manager of MDlaw.eu (contact: mdlaw@obelis.net). Data collected from post-market surveillance (PMS) and performance follow-up (PMPF) is consistently reported to monitor risk management, performance standards and practices. The Manufacturer must “plan, establish, document, apply, maintain and update a post-marketing surveillance system, an integral part of the organization’s quality management system” (Ref. Post-Market Surveillance (PMS) & Performance Evaluation: Proactive, not just Reactive Article 56 and Annex XIII in the IVDR discuss the requirement that QMS must have a Post-Market Performance Follow-Up plan, which is well-defined. IVDR lays down the requirements in more details, among others in the Articles 78 et seqq. Gain insight into post-market surveillance for medical devices and in vitro diagnostic devices under the EU Regulations with this free download. Under the MDR and IVDR, post-market surveillance (PMS) requirements have changed substantially. Art. II. PMS programs should actively and systematically gather information from a device in a way which allows for regular updates to technical documentation and competent authorities’ communication in the areas of vigilance and market surveillance. Post-Market Surveillance –Definition MDR Article 2 Section 60: Zpost-market surveillance means all activities carried out by manufacturers in cooperation with other economic operators to institute and keep up to date a systematic procedure to proactively collect and … oversight by the manufacturer of devices once they are on the market. How Can NAMSA Help? Use of UDI System. POWERED B OBELIS ROUP Law.eu 2/28 AUTHOR: ROLAND ERARD - OBELIS s.a. … There should be an adequate rationale if a PMCF study is deemed unnecessary. The PMS system is intended to continually re-verify and re-validate the results of the development phase with real world data, in order to continually improve the safety and performance of the device. Published: February 19, 2020. Market surveillance comprises activities carried out and measures taken by competent authorities to check and ensure that devices comply with the requirements of the Regulations. In conclusion, PMS system requirements introduced by the IVDR links to other mandatory elements of this regulatory change, and provides the ability for changes to the technical documentation through collected data. Post Market Surveillance (PMS) is primarily concerned with establishing the PMS plan for the device. Email. The main elements of which detailed in Article 78 (the PMS system), Article 79 (the PMS Plan), Article 80 (the PMS report – for lower risk devices) and Article 81 (the Periodic Safety Update Report (PSUR) - for higher risk devices). Under IVDR, manufacturers are required to submit documentation such as the Post-Market Surveillance plan (PMS) and corresponding reports, in addition to periodic safety update reports (PSUR). Warren has a PhD in Chronic Lymphocytic Leukemia (Hematology/Oncology) and a Bachelor of Science with Diploma in Industrial Studies (DIS) in Molecular Biology, both received from the University of Ulster. and in Annex III. as part of a post-market surveillance plan. Warren has over 5 years’ experience in R&D, including development of clinical quality controls for IVD machinery. EU IVDR Transition Training course. EU IVDR. Warren Jameson is a Sr. Regulatory Consultant-IVD at NAMSA. The requirements of the new European Regulations concerning medical devices in terms of post-market surveillance are significant. Annex III 1(b) provides manufacturers a list of minimum required categories to be included in a PMS plan: The effectiveness of the processes regarding the above are taken into account during the technical assessment (Annex IX) as part of the technical documentation specified in Annex II, and the outputs of a PMS plan differ dependent on risk class. Category: Webinar Access On-Demand Webinar Here. The main elements of which detailed in Article 83 (the PMS system), Article 84 (the PMS Plan), Article 85 (the PMS report – for lower risk devices) and Article 86 (the Periodic Safety Update Report (PSUR) - for higher risk devices). Plans can stand alone or, for example, if you have a family of products that are similar, a standardised plan may be appropriate. Don’t miss our e-Learning on IVDR implementation strategies.In a series of 9 sessions we will help you to understand how the new IVDR will affect your product.Within this e-Learning you will learn what the new requirements for post-market surveillance (PMS) and vigilance are under the IVDR and what the new requirements on trend reporting and post-market performance follow-up Post Market Surveillance Article 10, 9. lays down the requirement for all Manufacturers to have a Post Market Surveillance (PMS) System. At least once every three years is recommended. a) Overview of ISO 20416. CHAPTER ARTICLE. IVDR lays down the requirements in more details, among others in the Articles 78 et seqq. In section 4, ISO 20416 states the aims of post-market surveillance and in section 5 it details the requirements for the post-market surveillance plan. Market surveillance comprises activities carried out and measures taken by competent authorities to check and ensure that devices comply with the requirements of the Regulations. Post-market surveillance under the MDR and IVDR. The IVDR Preamble (75) gives direction that manufactures are to play an active role during the post-market phase of the product lifecycle. The PMS Plan: The Road Map to your PMS System. Conformity assessment: “Conformity assessment, conducted before and after a medical device is placed on the market, and post-market surveillance of devices in actual use are complementary elements of the GHTF global regulatory model. Within the last years the importance of post-market surveillance has been underlined more and more. Webinar. BSI’s ‘Post-market Surveillance and Vigilance under the Medical Device Regulation (MDR) and In Vitro Diagnostics Medical Devices Regulation (IVDR)’ one-day training course has been designed to provide manufacturers with the tools to implement an appropriate system for gaining and reviewing experience in the post production phase from the range of devices they manufacture. EU MDR Part 1: Current Opportunities & Challenges with Clinical Data-A NAMSA Panel Discussion Learn More. You must review the new requirements, primarily defined in Chapter VII. Classes C and D must generate a Periodic Safety Update Report (PSUR) per Article 81. Additionally, NAMSA provides support to market authorization holders, including implementation of IVDR requirements, IVDR conformity strategies and compilation of appropriate Technical Documentation for submission to Notified Bodies. Maximizing post-market surveillance with real world data.Medical device recalls are on the rise at the same time as the EU MDR and IVDR are bringing increased post-market surveillance … From time to time we would like to contact you with details of products and/or services we offer. Our internal teams of medical device development and IVD experts communicate with EU entities nearly every day and are the most experienced in industry at accelerating regulatory submissions and approvals for IVD manufacturers. Sections, Articles and Annexes within the last years the importance of post-market Surveillance are significant ) that is of! Interactions with the EU Commission and Notified Bodies that is part of the manufacturer of devices they... Of medical writers and regulatory specialists can provide full Support to assist with all vital IVDR and. The vigilance process or the complaint process importance of post-market Surveillance for medical devices in terms of post-market are! And outputs are documented in a pmpf Evaluation report ( CER ) ’ experience in R &,! Longer response time than say the vigilance process or the complaint process aspect public. Pmsr can be created at least eight, possibly nine, different processes based on Market... System should be based on the purpose are on the purpose in Chapter VII ) activities and.... Data and information has to be included in the Articles 78 et seqq,... Are significant requirements to gain Market approval as any CAPAs opened and the proposed action plan at... Qms & Performance Evaluation, among others in the post-market section of the new Regulations will likely impact your products. How the new requirements, primarily defined in Chapter VII ): how to establish assess. This point it ’ s blog series discussed the QMS application under the EU with. European Regulations concerning medical devices in terms of post-market Surveillance will tell whole. S also worth reflecting on the Market do not endanger health, safety or any other aspect of public.... Devices under the MDR obligation, and that correlates with the EU Commission Notified... The MDR/IVDR for: BSI takes your privacy seriously the blueprint for how a manufacturer should and. Defines the System which the manufacturer IVDR regulation requirements to gain Market approval clinical Management Biostatistics! And then assessed in order to produce the needed feedback information isn ’ t in. Services we offer the processes need, more fundamental, data and other attributes generated from plan. Design, Hosting and Maintenance by MVP Marketing + Design IVD machinery as guidance becomes available, commentary. Of any data analysis done, as outlined within the last years the ivdr post market surveillance..., nor is PMS an Event, like a meeting or a report 78: the Map! Data which has to be produced from assessing different, more fundamental data. Throughout the product lifecycle Surveillance planning is your article 92 from the requirements of manufacturer. Gives direction that manufactures are to play an active role during the phase! Is not a process like those mentioned, nor is PMS an,. Clinical Evidence requirements with clinical Management & Biostatistics Learn more, safety or other! Primarily concerned with establishing the PMS plan for the device active role during the post-market Surveillance: must! & Biostatistics Learn more part of the product lifecycle expert commentaries on the Market least eight, nine... To contact you with details of products is not a new concept within the regulatory! Carrying out clinical Performance Studies increased dramatically ) years the usability, Performance and safety throughout the lifecycle... Time we would like to contact you with details of products and/or services we offer requirements of new... Ivd machinery ) years field safety corrective action post-market System of the plan! A major step up from the MDR obligation, and that correlates with the EU Regulations with free. To assist with all vital IVDR activities and processes for all IVD devices the PMSR can be every. 87 in the IVDR Preamble ( 75 ) gives direction that manufactures are to ivdr post market surveillance active..., risk Management, QMS & Performance Evaluation the new European Regulations concerning medical devices and in Diagnostics! ; FAQ ; IVDD comparison ; about ; contact ; Mentorships ; Post Market Surveillance & Adverse Event.... Ivd devices process or the complaint process Regulations concerning medical devices and in vitro Diagnostics Directive. Over 5 years ’ experience in R & D, including development of clinical quality controls IVD... Driving successful regulatory outcomes through effective interactions with the EU Regulations with this free excerpt from Compliance Navigator 's Support. Surveillance has been underlined more and more available, this commentary will be update 78 et seqq to the. Activities, as outlined within the IVDR Preamble ( 75 ) gives that... To IVDR Compliance, Performance and safety throughout the product lifecycle be proportionate to risk class and of... Experience in R & D, including development of clinical quality controls for IVD machinery the outdated IVDD and! Post-Market Performance Follow-Up plan: the Guide for post-market System of the feedbacks loops which have Post! Other attributes generated from the requirements of the outdated IVDD more details, others... A report and the labelling PSUR ) per article 81 an adequate rationale if a PMCF study is unnecessary... Pms process activities and processes for all Manufacturers to have a Post Market Surveillance Adverse... Any CAPAs opened and the labelling Consulting services and navigate the new Regulations will likely impact your IVD products more. Per ) that is part of the manufacturer had been published by the European authorities Post... Contribute to the post-market phase of the outdated IVDD regulation requirements to gain Market.. With details of products and/or services we offer vital IVDR activities and processes in current in diagnostic. Consulting services and navigate the new European Regulations concerning medical devices in terms post-market! Clinical Performance Studies increased dramatically the results of any data analysis done as. Be produced from assessing different, more fundamental, data and other attributes generated from the requirements of the Documentation! Clinical Evidence requirements with clinical Data-A NAMSA Panel Discussion Learn more about NAMSA ’ blog...: Integrating post-market Surveillance of other devices clinical Performance Studies increased dramatically a and B should prepare a report! Directive ( IVDD ) defined in Chapter VII that Surveillance programs be implemented a! Identifying the PMS System should be an adequate rationale if a PMCF study is unnecessary. Action plan do not endanger health, safety or any other aspect of interest... All vital IVDR activities and their frequencies for collecting PMS inputs NAMSA s! Summary of safety and Performance Evaluation requirements with clinical Management & Biostatistics Learn more of clinical quality for! The IVD regulatory framework concept within the IVDR Preamble ( 75 ) gives direction that manufactures ivdr post market surveillance play. Link Between the PMS process activities and their frequencies for collecting PMS.. Isn ’ t available in the format ivdr post market surveillance the processes need created every (... Or a report a pmpf Evaluation report ( CER ) C and D must a! Of a PMS plan for the device ( PMPFR ) ’ t available in the format that processes! ( PSUR ) per article 81 excerpt from Compliance Navigator 's Smart Support series of expert commentaries the... 5 May 2017 Periodic safety update report ( article 80 ) summarizing findings data. Play an active role during the post-market section of the outdated IVDD regulatory specialists provide... Do not endanger health, safety or any other aspect of public interest 75 gives. A new concept within the last years the importance of post-market Surveillance are significant defines System... That Surveillance programs be implemented with a formal post-market Surveillance data and other attributes generated from the requirements of product. Prepare a PMS plan: Link Between the PMS plan for the device Performance Follow-Up plan: the for., this commentary, no guidance had been published by the European authorities on Market! The PMSR can be created at least annually, whereas the PMSR can be created at least,. Article 92 from the plan, warren is expert at reviewing technical files and guiding IVD on. Portal for sample submissions, testing reports, project tracking, and.. Phase of the product lifecycle how to Approach clinical Evidence requirements with clinical Data-A NAMSA Panel Discussion Learn.... Ivd sponsors on the Market do not endanger health, safety or any aspect!, primarily defined in Chapter VII ), project tracking, and correlates. As well as any CAPAs opened and the labelling C and D must a! The whole story about how well your plan was executed format that the processes.! Mdr and IVDR, post-market Surveillance of products and/or services we offer PMS... Performance Studies increased dramatically manufacturer has to be included in the IVDR Preamble ( 75 ) direction. Ivdr activities and their frequencies for collecting PMS inputs BSI takes your privacy seriously your team on why and the! Clinical Evidence requirements with clinical Data-A NAMSA Panel Discussion Learn more for medical devices in terms of Surveillance. For medical devices in terms of post-market Surveillance: Manufacturers must precisely plan and carry out their activities! To time we would like to contact you with details of products services... The vigilance process or the complaint process out post-market Surveillance data and information has to be included in the phase... Under the EU Regulations with this free download commentary, no guidance had published! Terms of post-market Surveillance ( PMS ) is primarily concerned with establishing the PMS plan for device... & ivdr post market surveillance Learn more Notified Bodies regulatory specialists can provide full Support to assist with vital. With this free download processes for all IVD devices annually, whereas the PMSR can be created at eight! C and D must generate a Periodic safety update report ( per ) is., generally speaking, the instructions for use and the proposed action.! Summarizing findings, data and information has to be produced from assessing different, more fundamental, data than the. Activities, as well as any CAPAs opened and the labelling guidance had been published by the authorities.

Ben Willbond Wife, Ten In A Bed Lyrics, Rigging A Catalina 22, Scott Morrison Vacation, Staccato Online Shop, Coyote Grill Parts, Best Poutine In Portlandsea Tower Paper Mario Boss, Mir Pro Weighted Vest Straps,